Companies & Industry »Company News
Alembic Pharmaceuticals Ltd - Company News

BSE   25 Apr 18 | 12:00 AM

518.25 3.6 (0.7%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 533573
Face Value: 2

NSE   25 Apr 18 | 12:00 AM

520.00 1.1 (0.21%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: APLLTD
Performance
1 Week : Rs 499.00 (3.86%)
1 Month : Rs 533.80 (-2.91%)
1 Year : Rs 611.15 (-15.20%)
change companytradenow

  • 25 Jul 17
    07:24 AM
    Shareholders demanding a board seat at Alembic, the oldest pharmaceutical firm in the country, to ensure better returns could trigger a similar trend elsewhere, said proxy advisory firms and corporate governance experts.
  • 24 Jul 17
    04:45 PM
    As drama unfolds in the Board room of the country's oldest pharmaceutical entity Alembic, with small shareholders pushing for a Board seat in Alembic Ltd to ensure better investor returns, shares of both Alembic Ltd and Alembic Pharma rallied in the
  • 11 Jul 17
    11:26 AM
    Alembic Pharmaceuticals rose 6% to Rs 545 on BSE in intra-day trade after the company said that it has received US Food & Drug Administration (USFDA) tentative approval for its abbreviated new drug application (ANDA) for Dabigatran Etexilate Capsules,
  • 30 Oct 16
    01:22 AM
    The US market has been the cause of worry of some of the major pharmaceutical players this quarter, dragging their net profit and revenues.
  • 25 Oct 16
    03:18 PM
    Vadodara-based Alembic Pharmaceuticals Ltd posted a 58.6 per cent drop in net profit for the quarter ended September 30, 2016, to Rs 119 crore as the corresponding quarter last fiscal included revenues and profits from a Para IV new product launch in the
  • 29 Jul 16
    12:36 AM
    Alembic Pharmaceutical Limited has reported a 45 per cent rise in net profit to Rs 102.02 crore in first quarter of financial year 2016-17 as against Rs 70.17 crore in corresponding period of 2015-16. The company's net sales rose by 25 per cent to Rs
  • 08 Jul 16
    01:43 PM
    Shares of Alembic Pharmaceuticals and Cadila Healthcare have rallied by up to 8% on the BSE in intra-day trade after these companies announced that they have received Establishment Inspection Report (EIR) from that US Food and Drug Administration (USFDA)
  • 21 Apr 16
    11:31 AM
    Alembic Pharmaceuticals (APL) has move higher by 8% to Rs 616 on the BSE after the company announced that it has formed 60:40 joint venture (JV) with Orbicular to develop & commercialise dermatology products for global markets.
  • 29 Mar 16
    03:18 PM
    Vadodara-based Alembic Pharmaceuticals, which has seen the share of exports in its turnover increase three-fold in the last five years, is likely to receive some minor observations (as a Form 483) from the US drug regulator for its Panelav facility.
  • 31 Jul 15
    03:42 PM
    Alembic Pharmaceuticals today reported 8.05 per cent rise in consolidated net profit to Rs 69.88 crore for the first quarter ended June 30, 2015-16, mainly on account of robust sales.
  • 19 Jun 15
    02:08 PM
    Shares of Alembic Pharmaceuticals have rallied 10% to Rs 674 on back of heavy volumes on the bourses. It opened at Rs 623 and hit a record high of Rs 693 on the BSE.
1|2|3|Next
Widgets Magazine

Sensex

Company Price Gain (%)
Bharti Airtel419.803.37
TCS3,467.902.43
M & M854.251.88
Infosys1,160.900.61
Power Grid Corpn207.200.58
Widgets Magazine

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine